相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients
Yvonne Nadine Fahmueller et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy
Oliver J. Stoetzer et al.
TUMOR BIOLOGY (2013)
Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma
Sandro Jube et al.
CANCER RESEARCH (2012)
Immunogenic Tumor Cell Death Induced by Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma
Yoshiyuki Suzuki et al.
CANCER RESEARCH (2012)
Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma
Hye Won Chung et al.
CANCER SCIENCE (2012)
On the armament and appearances of human myeloid-derived suppressor cells
Isabel Poschke et al.
CLINICAL IMMUNOLOGY (2012)
High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases
Wei Yan et al.
HEPATOLOGY (2012)
HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells
Clarissa Anni Wild et al.
INTERNATIONAL IMMUNOLOGY (2012)
Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens
Koji Kono et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Tumor immunity times out: TIM-3 and HMGB1
Daolin Tang et al.
NATURE IMMUNOLOGY (2012)
Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
Shigeki Chiba et al.
NATURE IMMUNOLOGY (2012)
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer
Clarissa A. Wild et al.
ORAL ONCOLOGY (2012)
Regulatory T Cells in γ Irradiation-Induced Immune Suppression
Hugh I. McFarland et al.
PLOS ONE (2012)
Diagnostic Significance of Serum HMGB1 in Colorectal Carcinomas
Hanna Lee et al.
PLOS ONE (2012)
Regulatory mechanisms of nucleic acid-mediated innate immune responses in the tumor microenvironment
Masahisa Jinushi
ONCOIMMUNOLOGY (2012)
Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39
Mickael Michaud et al.
ONCOIMMUNOLOGY (2012)
Abscopal but desirable The contribution of immune responses to the efficacy of radiotherapy
Guido Kroemer et al.
ONCOIMMUNOLOGY (2012)
Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress
Dimitrios Mougiakakos et al.
BLOOD (2011)
Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
Oliver Kepp et al.
CANCER AND METASTASIS REVIEWS (2011)
Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response
Jitka Fucikova et al.
CANCER RESEARCH (2011)
Prognostic Impact of ΔTAp73 Isoform Levels and Their Target Genes in Colon Cancer Patients
Beatriz Soldevilla et al.
CLINICAL CANCER RESEARCH (2011)
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Mickael Michaud et al.
SCIENCE (2011)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
Julie Vincent et al.
CANCER RESEARCH (2010)
Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
Laurence Zitvogel et al.
CLINICAL CANCER RESEARCH (2010)
Elevated expression of HMGB1 in squamous-cell carcinoma of the head and neck and its clinical significance
Yong Liu et al.
EUROPEAN JOURNAL OF CANCER (2010)
Immunogenic death of colon cancer cells treated with oxaliplatin
A. Tesniere et al.
ONCOGENE (2010)
Naturally occurring regulatory T cells show reduced sensitivity toward oxidative stress-induced cell death
Dimitrios Mougiakakos et al.
BLOOD (2009)
Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer
Koji Kono et al.
CANCER SCIENCE (2009)
The immunogenicity of tumor cell death
Oliver Kepp et al.
CURRENT OPINION IN ONCOLOGY (2009)
Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer
Hye Won Chung et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies
Lionel Apetoh et al.
CANCER RESEARCH (2008)
Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma
Yoshiki Mizukami et al.
CANCER SCIENCE (2008)
Immunogenic cancer cell death: a key-lock paradigm
Antoine Tesniere et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Galectin-9 Increases Tim-3+ Dendritic Cells and CD8+ T Cells and Enhances Antitumor Immunity via Galectin-9-Tim-3 Interactions
Keiko Nagahara et al.
JOURNAL OF IMMUNOLOGY (2008)
New roles for TIM family members in immune regulation
Vijay K. Kuchroo et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
IMMUNOLOGICAL REVIEWS (2007)
Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells
Ana C. Anderson et al.
SCIENCE (2007)
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA
Stanimir Ivanov et al.
BLOOD (2007)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE
Jane Tian et al.
NATURE IMMUNOLOGY (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
The secretion of HMGB1 is required for the migration of maturing dendritic cells
Ingrid E. Dumitriu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Leveraging the immune system during chemotherapy: Moving calreticulin to the cell surface converts apoptotic death from Silent to immunogenic
Michel Obeid et al.
CANCER RESEARCH (2007)
The extracellular release of HMGB1 during apoptotic cell death
Charles W. Bell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
ERp57 and PDI: multifunctional protein disulfide isomerases with similar domain architectures but differing substrate-partner associations
P. Maattanen et al.
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE (2006)
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
C Zhu et al.
NATURE IMMUNOLOGY (2005)
Induction chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus: Impact of increased dosage on long-term results
G de Manzoni et al.
ANNALS OF THORACIC SURGERY (2005)
Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity
E Suzuki et al.
CLINICAL CANCER RESEARCH (2005)
Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis
P Marini et al.
BMC CANCER (2005)
Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
S Demaria et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
HMGB1 is an endogenous immune adjuvant released by necrotic cells
P Rovere-Querini et al.
EMBO REPORTS (2004)
Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus
S Ishikura et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance
A Sanchez-Fueyo et al.
NATURE IMMUNOLOGY (2003)
Death and anti-death: Tumour resistance to apoptosis
FH Igney et al.
NATURE REVIEWS CANCER (2002)
Perioperative supplementation of EPA reduces immunosuppression induced by postoperative chemoradiation therapy in patients with esophageal cancer
K Takagi et al.
NUTRITION (2001)
Radiosensitivity of human squamous carcinoma cell lines is associated with amount of spontaneous DNA strand breaks
AG Polischouk et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
分享论文
